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Residual structure in the Alzheimer’s disease peptide: probing
the origin of a central hydrophobic cluster
Shengsheng Zhang, Nicole Casey and Jonathan P Lee
Background: Structure–function studies on the Alzheimer’s disease peptide
show that a central hydrophobic cluster — Aβ(17–21), LVFFA — is a prominent
structural feature linked to plaque competence. The origin and stability of this
cluster was probed in a 17-residue fragment which includes flanking residues
that potentially help stabilize the cluster.
Results: After residue substitution, the measurement of pKas, amide exchange
rates and other NMR data show that any coulombic interactions between His14
and Glu22 are not required for the stability of the central hydrophobic cluster. In
contrast, a single substitution within the cluster disrupts its integrity and causes
the largest pKa shift for flanking residues, while increasing the solvent
accessibility of the backbone.
Conclusions: The integrity of the structurally dominant cluster relies primarily
upon local hydrophobic interactions, rather than on interactions between the
sidechains of charged flanking residues. Moreover, the conformational
disposition of the cluster affects the pKas of flanking residues, underscoring its
structural dominance.
Introduction
The amyloid peptide (Aβ) is believed to be the principal
constituent of the senile amyloid deposits which are con-
sidered a pathological hallmark of Alzheimer’s disease
(AD) [1] and there is growing support for the hypothesis
that the formation of amyloid deposits is one of the
causative processes in AD [2–4]. If this controversial
hypothesis is correct, then the pathology of AD may
emerge as a mechanistic paradigm within the growing
family of human amyloidoses [5]. One obvious test of the
‘amyloid hypothesis for AD’ would be to interrupt the for-
mation of amyloid deposits and then monitor the senile
dementia and neurodegeneration that are normally
observed in AD. Understanding the precise molecular fea-
tures underlying the formation of amyloid deposits is
therefore of significant biomedical interest. In addition,
the phase transition of soluble Aβ molecules onto insolu-
ble amorphous amyloid deposits represents an intriguing
problem in polypeptide thermodynamics, and is likely to
have similarities to events in protein folding. Conse-
quently there is also general scientific interest in deci-
phering the molecular basis underlying the kinetics and
thermodynamics that govern this phase transition.
The sequence of the Aβ peptide includes two hydropho-
bic regions — central (residues 17–21) and carboxy ter-
minal (residues 31–43) — surrounded by stretches of
polar or charged residues [6]. Following the initial report
of the Aβ peptide sequence [6], it has been suspected
that the hydrophobic residues may have an important
role in solution conformation, as well as in the architec-
ture of amyloid assemblies. Numerous soluble proteins
have clusters of hydrophobic residues toward one side of
an amphipathic α helix, or on one side of a β strand,
which function to hold together different elements of
secondary structure within their cores. It was subse-
quently shown that substitutions within residues 17–20
of the central hydrophobic region of Aβ peptide con-
geners resulted in altered aggregation properties (e.g. at
high concentration and in the absence of preformed tem-
plates) [7]. Conformational analysis of Aβ(10–35)-NH2 in
aqueous solution then revealed a non-native conforma-
tion with a local intramolecular central hydrophobic
cluster (CHC, residues 17–21), and it was further sur-
mised that the solution conformation of Aβ(10–35)-NH2
is ‘trapped’ in a metastable state, with the cluster func-
tioning as a dominant nucleus for the pH-dependent
propagation of a compact hydrophobic core [8,9]. Inter-
estingly, the CHC, along with many flanking residues,
adopts similar conformations in the N-terminal 28-mer
Aβ(1–28) and in the overlapping region of the central 26-
mer Aβ(10–35)-NH2 [8]. However, with the presence of
the six non-overlapping C-terminal residues in the
central 26-mer (i.e. residues 29–35), not only does the
plaque-competent activity appear (deposition at low con-
centration onto an authentic amyloid template), but
these residues also increase the stability of the compact
core enough to allow detailed structural analysis in water
[8,9]. More recently, the integrity/foldedness of the CHC
within Aβ(10–35)-NH2 was found to correlate with
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plaque competence, further supporting the importance
of this region for both structure and activity [8,10].
Local sidechain clustering in short linear polypeptides is a
well-established phenomenon, with an important role in
protein folding [11,12]. The sidechains of hydrophobic
residues are also known to cluster into metastable cores
that function as folding intermediates [13,14]. In addition,
there has been interest recently in identifying the poten-
tial occurrence of hydrophobic clusters in natively folded
systems by analysis of two-dimensional protein data (e.g.
hydrophobic cluster analysis (HCA) [15]). We believe
that the Aβ peptide is an example of a metastable system
that exhibits mixed behavior related to all these para-
digms. We also suspect that self-association reactions
(both solution aggregation and deposition onto authentic
amyloid deposits) have intimate links to the global confor-
mational and thermodynamic equilibria of individual mol-
ecules in solution. Furthermore, because disruption of the
CHC destabilizes the solution conformation, while simul-
taneously completely abolishing in vitro plaque compe-
tence [10], it is likely that the CHC residues have a key
role in the thermodynamic positioning of soluble Aβ
within conformational space. This would ultimately set
the stage for creation of the driving force underlying for-
mation of amyloid deposits. Consequently, we have begun
to investigate the origins of conformational stability for the
CHC, and specifically to resolve whether a putative long-
range salt bridge between residues in the two flanking
regions [8] has a key role in stabilizing the CHC.
In water solution the 17 amino acid fragment Aβ(12–28)
shows NMR evidence of residual structure very similar to
that found in metastable plaque-competent Aβ(10–35)-
NH2 ([8,9]; J.P.L., unpublished data) as well as in
Aβ(1–40) ([9]; J.P.L., unpublished data). We compared
this 17-mer with three different peptides substituted at
either His13, Phe19 or Glu22 (Figure 1). Peptides with
substitutions at positions 13 and 22 were chosen because
they correspond to genetic variations found in rodents [16]
or among the ‘Dutch AD’ population [17], respectively,
and were studied to determine how two naturally occur-
ring substitutions of charged residues in the flanking
regions of the CHC may alter the pKa values for other
charged residues, as well as affect the cluster’s stability.
The third substitution at position 19 of the 17-mer corre-
sponds to a previously characterized unnatural substitution
made in the plaque-competent 26-mer Aβ(10–35)-NH2
which rendered it inactive (i.e. plaque incompetent)
towards authentic amyloid deposits obtained from fresh
human tissue, while simultaneously decreasing the folded-
ness of the peptide in solution [10].
We report extensive two-dimensional 1H NMR data used
to probe for pKa shifts among the ionizable residues in the
four peptides, as might be expected if significant long-
range electrostatic interactions existed [18]. The NMR
data were also used to correlate changes in ionization state
with changes in NMR chemical shifts for neighboring
residues, revealing site-specific information about pH-
dependent changes in conformation, or conformational
stability. 1H T1 relaxation measurements of the amide
hydrogen atoms of wild-type Aβ(12–28) and
Aβ(12–28)F19T were used as an initial probe of relative
backbone stability. However, to decipher the precise
chemical differences in the four polypeptide backbones,
isothermal water exchange times for backbone amide
hydrogen atoms were then measured using the NMR
water exchange (WEX) method [19,20]. The data show
that the CHC remains the most prominent folding
element, dominating the conformation even within this
relatively short Aβ congener. In addition, no significant
evidence supporting the presence of an intramolecular salt
bridge could be found, and it seems more likely that a
combination of steric and hydrophobic forces are domi-
nant in stabilizing the residual structure of these truncated
Aβ fragments. Finally, we propose a potential mechanism
for the pH-dependent increase in foldedness seen in Aβ
and its congeners [8].
Results
1H NMR assignments, αaH and sidechain chemical shifts
Assignments of 1H spin systems for Aβ(12–28) and the
three related congeners were performed at ~pH 2.0 and
~pH 7.0 using standard methods [21], and closely agree
with previous studies of Aβ(1–28) [8,22], Aβ(12–28) [23],
Aβ(10–35)-NH2 ([8,9]; J.P.L., unpublished data), and
Aβ(1–40) ([9]; J.P.L., unpublished data; assignments are
given in Supplementary material published with this
paper on the internet). Differences between the αH
chemical shift and a reference value [24] for the 12–28
region, although found within the context of full-length
Aβ, and the four 17-mers at ~pH 7.4 are shown in
Figure 2. The NH/αH resonances (measured in F2 and
F1 respectively) for N-terminal residues of Aβ fragments
beginning at either position 10 or 12 are very broad at mid-
range pH values (e.g. intermediate exchange regime, data
not shown) and consequently the precision of measure-
ments for residues 12–14 is limited compared with those
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Figure 1
Amino acid sequences of the wild-type Aβ(12–28) and the three
congeners (substituted residues are in bold).
Aβ(12–28): H2N-VHHQKLVFFAEDVGSNK-COOH
Aβ(12–28) H13R: H2N-VRHQKLVFFAEDVGSNK-COOH
Aβ(12–28) F19T: H2N-VHHQKLVTFAEDVGSNK-COOH
Aβ(12–28) E22Q: H2N-VHHQKLVFFAQDVGSNK-COOH
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for the remaining 14 residues. It is noteworthy that, except
for the N- and C-terminal residues, the αH chemical shift
data for each residue in Aβ(1–40) (and the plaque-compe-
tent 26-mer Aβ(10–35)-NH2 (data not shown)) differ by
less than 0.03 ppm from the data from plaque-incompe-
tent Aβ(12–28), and were nearly invariant throughout the
pH titrations described below. The data show that the
residual structure in the 17-mers is similar to the
metastable structure seen in Aβ(10–35)-NH2 and
Aβ(1–40) when in water solution ([8,9]; J.P.L., unpub-
lished data). The data also argue against significant back-
bone conformational changes as a result of gain or loss of
charges on sidechain atoms, supporting the notion that the
pH-dependent increase in foldedness seen for Aβ con-
geners [8] results from stabilization of a conformation
closely related to a small family of pre-existing conformers
([9]; J.P.L., unpublished data). Of additional importance,
complete chemical shift index (CSI) analysis [24] (data
not shown) predicts that this 17-residue segment of Aβ
peptides is completely devoid of any α-helical or β-sheet
secondary structure; this is consistent with high-resolution
structural data for Aβ(10–35)-NH2 in water solution ([8,9];
J.P.L., unpublished data) but in sharp contrast to results
obtained for a variety of Aβ fragments studied in other sol-
vents [22,25–29].
Relatively small αH chemical-shift differences were
observed for each of the three substituted 17-mers,
arguing against extensive conformational reorganization as
a result of these three substitutions. Both the H13R
(‘rodent’) and E22Q (‘Dutch’) substituted 17-mers corre-
spond to naturally occurring congeners and were con-
structed to probe for evidence of stabilizing coulombic
interactions between charged sidechains at (or near) posi-
tions 13 and 22. The αH shifts for the Aβ(12–28)H13R
and Aβ(12–28)E22Q peptides show small differences for
the residues in close proximity to the site of substitution
(~± 1 residue), and in both cases insignificant changes in
αH chemical shifts were detected for residues within the
hydrophobic cluster, or at sites more than ~± 1 residue
away from the site of substitution. In contrast, substituting
a Thr residue for Phe19 results in larger changes in the
αH chemical shifts for most of the residues between posi-
tions 13 and 22 (except Lys16 and Phe20), and causes the
largest change in chemical shift for the αH atom of Lys28.
Furthermore, 0.05–0.1 ppm upfield shifts were observed
for the β-hydrogen atoms of Leu17, Val18 and Lys28 in
Aβ(12–28)F19T (data not shown), similarly to what has
been observed following comparison of Aβ(10–35)-NH2
with Aβ(10–35)-NH2F19T [10]. Consequently, while the
chemical-shift differences are modest, a single substitu-
tion within the CHC causes more global changes in the
backbone atoms than substitutions made in either of the
flanking regions. All NMR spectra measured on Aβ pep-
tides in our laboratory in water solution have shown a ‘dis-
crete marker’, observed as an upfield shift of γ-methyl
resonances of Val18. Following structural analysis of
Aβ(10–35)-NH2 ([8,9]; J.P.L., unpublished data) this
effect has been primarily attributed to the ring currents of
Phe20, and to a lesser extent Phe19, providing corroborat-
ing evidence of the intactness of the hydrophobic cluster.
Figure 3 shows the characteristic behavior of the Val18
γ-methyl resonances for plaque-competent Aβ(1–40) and
Aβ(10–35)-NH2, and plaque-incompetent Aβ(10–35)-
NH2F19T [10], as well as comparable behavior for this
marker within the four 17-mers studied here. The F19T
substitution in both the Aβ(10–35)-NH2F19T and
Aβ(12–28)F19T fragments abolishes this marker in a
similar manner, whereas other substitutions in the 17-mers
do not. Conventional high-resolution structural analyses of
both Aβ(10–35)-NH2F19T and Aβ(12–28)F19T are not
feasible because of relatively high conformational flexibil-
ity, and unfortunately more precise conformational details
on the effect of the F19T substitution are not available at
this time.
pKa determination
Because previous work [8] has shown that the sidechains
of His14 (and His13) are in the proximity of Glu22 in the
plaque-competent 26-mer Aβ(10–35)-NH2 (Table 1), and
given that many of the NMR data for the 17-mers are
comparable to those for longer Aβ sequences, it seemed
plausible that a general feature of the peptide might be a
stabilizing coulombic interaction between residues located
on either side of the CHC. To probe specifically for
intramolecular coulombic interactions, the sidechain pKa
values were determined by monitoring chemical-shift
changes in two-dimensional TOCSY NMR spectra
(Figure 4). Titrations of His13, His14, Glu22 and Asp23
were carried out from pH 2.0 to pH 9.7 by acquiring 32
two-dimensional spectra, for each of the four 17-mers
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Figure 2
∆δHα of Aβ peptides compared with a CSI reference value [24]
(substituted residues are underlined).
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(Figure 5). Because of increasing line broadening and dra-
matic loss of signal intensity, the β- and γ-methylene reso-
nances of Glu22 in the wild-type and H13R-substituted
17-mers were below reliable detection for four to five of
the data points just before the ‘end’ of the titration curves,
but with increasing pH eventually recovered to acceptable
line shapes. To probe whether the absence of four or five
data points from a full set of 32 points would result in sig-
nificant errors in pKa determinations, the corresponding
points for Glu22 in the Aβ(12–28)F19T data set, and for
Asp23 in all four data sets, were deleted, the results
recomputed and compared. In all cases only small differ-
ences were observed, and in all cases these differences
were within the original calculated errors (data not shown)
and therefore judged of relatively minor consequence.
Table 2 shows the difference from literature intrinsic pKa
values [30], and Figure 6 plots the magnitude of δpKa for
the three substituted 17-mers with respect to Aβ(12–28).
On the basis of the proximities in Table 1, and assuming
no conformational response to ionization, and also using a
nominal dielectric of ~78.0 for water, the range of pKa
shifts is estimated to be approximately ± 0.5–2.0 units for
the interaction of His14 with Glu22 (shortest distance),
and for His13 with Glu22 (longest distance) (respectively).
However, interpretation of pKa shifts for biopolymers in
water solution is complicated by at least three system-spe-
cific features — the conformational response to gain or
loss of a charge; the ~20-fold difference in dielectric con-
stant between the interior of biopolymers and water; and
the possible association of soluble counter ions with
charged atoms of the biopolymer.
Comparing the pKa values for Aβ(12–28)H13R with
Aβ(12–28), the differences are less than 0.05 pKa units for
all three residues (His14, Glu22 and Asp23) and only
slightly greater than the calculated errors of ± 0.02. These
data suggest that potential direct coulombic interactions of
His13 with His14, Glu22 or Asp23 are minor compared
with the magnitude of the system-specific effects men-
tioned above. As the backbone does not undergo a large-
scale conformational change, with sidechain chemical
shifts (and coupling constants (data not shown)) showing
the major response, conformational changes that might
alter the distances between charges are likely to contribute
only a relatively modest amount to the small observable
pKa shifts. Furthermore, because at all four sites the gain
or loss of charge involves a neutral species in conjunction
with a charged species, it becomes necessary also to con-
sider that the charged forms possess a significantly greater
solvation imperative, and compared with free ions in solu-
tion the charged sidechain atoms are also expected to
demonstrate greater affinities for soluble counter ions.
Hence, from the data it is more likely that the charged
sidechain atoms are more intimate with solvent (and
perhaps soluble counter ions) than with each other. 
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Figure 3
Methyl resonance region of Aβ peptide spectra. (a) Aβ(12–28)H13R;
(b) Aβ(12–28)E22Q; (c) Aβ(12–28)F19T; (d) Aβ(12–28);
(e) Aβ(10–35)-NH2F19T; (f) Aβ(10–35)-NH2; and (g) Aβ(1–40). The
primary CHC ‘intactness marker’ resonance is from the γ-methyl (pro-
R) group of Val18, typically shifted to ~ 0.72 ppm in all spectra except
the (c,e) spectra, where Phe19 is substituted with Thr.
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Table 1
Average charged heavy atom separation 〈árij〉ñ (Å) in
Aβb(10–35)-NH2 (J.P.L., unpublished data).
His14 Glu22 Asp23
His13 10.6 12.7 11.5
His14 3.60 6.20
Glu22 7.70
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Figure 4
An example of the NMR data used to monitor
the pH titrations of ionizable residues in
amyloid peptides. ‘Slices’ (at the ω2 shift of
the Glu22 HN resonance in Aβ(12–28)) from
each of the different two-dimensional TOCSY
spectra recorded between pH 2.07 (top) and
9.61 (bottom). The 200 Hz section of the ω1
dimension shown in each trace contains Hγ
resonances for Glu22, displaying typical
sigmoidal behavior.
1480 1460 1440 1420 1400 1380 1360 1340 1320 Hz
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Figure 5
1H NMR data extracted from spectra such as
that in Figure 4, plotted across the pH titration
range for ionizable residues in Aβ peptides.
(a) His13; (b) His14; (c) Glu22; and
(d) Asp23.
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While the integrity of the CHC does not appear to be
affected by the H13R substitution, this particular substi-
tution probes for secondary effects rather than directly
testing whether a stabilizing interaction exists between
His14 and Glu22. On comparison of the pKa values for
Aβ(12–28) and Aβ(12–28)E22Q the differences were
found to be less than the uncertainty of the measure-
ments (~± 0.02 pKa units). The absence of measurable
‘secondary’ (at His13 and Asp23) as well as ‘reciprocal’ (at
His14) pKa shifts, and the lack of detectable conforma-
tional changes for the CHC, provide strong evidence that
any coulombic interaction between His14 and Glu22 does
not contribute directly to the stability of the cluster.
Comparing the data for the pKa values of Asp23 in the
presence of either Glu22 or Gln22 with data from small-
molecule studies of pKa shifts for dicarboxylic acids of
various lengths [31] reveals a paradox due to the pre-
dicted pKa shift of at least ~± 0.3 units. It follows that, as
for the results from the H13R substitution, the small con-
formational response to the E22Q substitution along with
a pKa shift of ~0 strongly suggest that a substantial solva-
tion imperative (perhaps including interaction with
soluble counter ions) provides a more energetically favor-
able mechanism for interactions with the charged
sidechain atoms than having the sidechains interacting
with each other.
pKa measurements for Aβ(12–28)F19T revealed unex-
pected behavior, showing a relatively large increase in pKa
for Glu22 (~ 0.4 pKa units) whereas the values for the
other three residues also increased, but more modestly (no
reciprocal pKa decrease was detected). Because the largest
pKa shift resulted from substitution of a residue which is
both non-adjacent to position 22 and non-charged, these
data agree with the chemical-shift data and buttress the
notion that the CHC remains a dominant structural
feature within these 17-mers, affecting both conformation
and chemical properties of residues well beyond the core
of the cluster. The F19T substitution causes the molecule
to ‘relax’ (see both above and below), and the significant
decrease in conformational restriction associated with the
CHC may be partially linked to a modest increase in con-
formational restriction in close proximity to Glu22. It
would follow that the increase in the pKa for Glu22
reflects a decrease in either the solvation efficiency and/or
interaction with soluble counter ions, and would be consis-
tent with the previous data interpretation for the H13R
and E22Q substitutions.
Amide hydrogen atom relaxation studies
As an initial probe into how the F19T substitution might
alter the mobility and solvent exposure of backbone
atoms, T1 relaxation times were measured via a modified
saturation recovery sequence which incorporates ware-
form gradient suppression (WGS) water suppression [8].
Figure 7 compares the relaxation rates (1/T1) for the
amide hydrogen atoms of Aβ(12–28) and
Aβ(12–28)F19T. Substitution at position 19 significantly
increases the relaxation rates for most backbone amide
hydrogen atoms, almost doubling the rate at position 16
(directly adjacent to the amino side of the CHC) as well
as at position 25 (four residues away from the carboxyl
side of the CHC). These data further corroborate the
global impact of a single amino acid substitution within
the structurally dominant CHC. However, although
relaxation experiments are useful as site-specific probes
418 Folding & Design Vol 3 No 5
Table 2
Intrinsic pKa (pKa int) and effective pKa (pKa eff) values.
pKa eff
Residue pKa int WT H13R F19T E22Q
His13 6.4 6.11 ± 0.02 6.13 ± 0.03 6.09 ± 0.03
His14 6.4 6.27 ± 0.02 6.22 ± 0.01 6.32 ± 0.02 6.26 ± 0.02
Glu22 4.5 4.42 ± 0.01 4.49 ± 0.02 4.79 ± 0.03
Asp23 4.0 3.90 ± 0.02 3.92 ± 0.02 3.97 ± 0.01 3.92 ± 0.01
Figure 6
∆pKa shifts for the His13, His14, Glu22 and
Asp23 residues in each of the substituted Aβ
congeners, with respect to the pKa of the
wild-type Aβ(12–28).
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of altered backbone behavior, the data cannot specifically
determine whether these differences arise from altered
mobility, increased amide hydrogen exchange with
solvent or a combination of both.
Exchange rates for amide hydrogen atoms
Isothermal exchange lifetimes were then measured using
an adaptation of the WEX [19,20] pulse sequence.
Exchange lifetimes were measured for each of the four
17-mers and protection factors were calculated according
to Bai et al. [32] (Table 3). Exchange data could not be
determined for residues 13–15 due to signal overlap and
signal broadening. For residues 26–28 the protection
factors are approximately 38-fold higher than the protec-
tion factors for residues 16–25, perhaps because of the
close proximity of the terminal carboxylate which may
inhibit base-catalyzed amide hydrogen exchange, and
therefore the three C-terminal residues were not consid-
ered in the analysis. The wild-type peptide had the
highest mean protection factor, followed by the E22Q,
H13R and F19T substituted peptides (281, 228, 171 and
167, respectively). These results are consistent with the
absence of hydrogen bonding associated with regular
repeating secondary structure, and modest protection
due to the presence of residual structure [33–35]. The
E22Q-substituted peptide also had three anomalous
changes in protection factors. Gln22 and Asp23 increased
to ~150% with respect to wild type, while Val24
decreased to 37%, almost the largest decease seen any-
where among the three substituted peptides. The E22Q
substitution therefore causes a significant local perturba-
tion, but only a most modest global change to the chemi-
cal environment of the backbone. The H13R-substituted
peptide had a more significant global effect compared
with the E22Q substitution (Table 3), but the only
anomalous change was measured for Lys16, which
increased to 169% of the wild type. These data suggest
that the presence of the charged arginine sidechain
instead of the neutral histidine sidechain has a significant
local effect, as well as a moderate global effect, compared
with the E22Q-substituted peptide. In contradistinction,
the F19T substitution caused the most intense global
reduction in protection factors and, along with strong
local effects, also showed more long-range effects. The
protection factor for Thr19 increased to 145% of wild
type, while that for Val18 was reduced to just 23% of
wild type (the greatest decrease seen). But more strik-
ingly, Val24 (i+5) was reduced to only 32% of the wild
type (the second largest decrease), showing that a substi-
tution at position 19 causes a greater effect at position 24
than does substitution at position 22. It is worth noting
that within the collapsed-coil conformation of Aβ(10–35)-
NH2, the amide hydrogen atoms for both Val18 and
Val24 are well protected from solvent compared with
other residues ([8,9]; J.P.L., unpublished data). Hence
differences in amide hydrogen atom exchange rates inde-
pendently reveal that both the H13R and E22Q substitu-
tions reduce, but do not abolish, local foldedness,
whereas the F19T substitution causes a larger, more
global, reduction in foldedness, specifically abolishing
evidence of residual CHC-based structure.
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Figure 7
Comparison of 1H longitudinal relaxation rates for the amide hydrogen
atoms in Aβ(12–28) and Aβ(12–28)F19T.
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Table 3
Protection factors for amide hydrogen atom exchange.
WT E22Q H13R F19T
Residue (P/103) (P/103) (P/103) (P/103)
12
13
14
15
16 0.29 0.26 (90) 0.49 (169) 0.38 (131)
17 0.16 0.12 (75) 0.09 (56) 0.09 (56)
18 0.26 0.19 (73) 0.14 (54) 0.06 (23)
19 0.20 0.15 (75) 0.12 (60) 0.29 (145)
20 0.29 0.27 (93) 0.18 (62) 0.23 (79)
21 0.55 0.39 (71) 0.35 (64) 0.29 (53)
22 0.23 0.34 (148) 0.13 (57) 0.11 (48)
23 0.18 0.27 (150) 0.12 (67) 0.11 (61)
24 0.19 0.07 (37) 0.11 (58) 0.06 (32)
25 0.38 0.27 (71) 0.30 (79) 0.27 (71)
26 1.02 1.17 (115) 0.96 (94) 0.88 (86)
27 3.11 2.07 (67) 2.08 (67) 1.91 (61)
28 35.66 32.09 (90) 4.80 (13) 10.98 (31)
〈16–25〉 〈0.281〉 〈0.228〉 〈0.171〉 〈0.167〉
Values in parentheses are percentages with respect to the 
wild-type value.
Discussion
Within water solution the CHC and its flanking residues
adopt similar backbone conformations within the context
of Aβ(1–40), Aβ(10–35)-NH2 and Aβ(12–28), as well as
within substituted versions of these peptides (provided the
core residues remain intact). Moreover, the importance of
the CHC region has been linked to both high-concentra-
tion aggregation [7] and deposition onto authentic amyloid
deposits at physiological concentrations [10]. The current
work addresses the issue of whether the CHC found
within Aβ is formed as an independent conformational
feature, or whether stabilization of this feature relies upon
interactions between residues that flank both sides of the
CHC. Specifically, pH-dependent increases in foldedness,
as well as the close proximity of the His14 and Glu22
sidechains, have previously ([8,9]; J.P.L., unpublished
data) raised the issue of whether the stability of the CHC
might depend upon a coulombic interaction between these
two residues. The data presented here argue against spe-
cific coulombic interactions between these residues as a
prerequisite to formation of the CHC. Moreover, substitu-
tions of charged residues at positions 13 and 22 do not
overcome the conformational dominance of the CHC. It
follows that the CHC adopts a conformation which is pri-
marily dependent upon local interactions and, conse-
quently, in the absence of coulombic and internal
hydrogen-bonding interactions, conformational stabiliza-
tion must largely depend upon steric and hydrophobic
forces to support the residual structure that exists within
these highly truncated peptides. It is also apparent that the
strength of the local interactions within the CHC when
dissolved in water solution is greater than the conforma-
tional forces arising from additional flanking residues.
Within this part of conformational space, where qualita-
tively structure appears non-native, the CHC appears as a
dominant feature. Thus it becomes of significant interest
to determine whether the same residues cluster together
into a dominant structural feature in either the transmem-
brane amyloid precursor protein (APP) (presumably native)
or insoluble amorphous amyloid deposits or, alternatively,
whether the residues of the CHC adopt different conform-
ers from those found in solution. Clearly, whether the
CHC persists within all molecular contexts may be an
important consideration in designing strategies to alter the
physiological effects of Aβ.
The presence of a dominant CHC which imposes limits on
the solvent accessibility to backbone atoms could also
hinder the solvation of the ionizable sidechains of flanking
residues. It would follow that the pH-dependent increase
in foldedness seen with Aβ(10–35)-NH2 is most probably
due to a solvation imperative associated with the ionized
form of the sidechains, rather than with long-range coulom-
bic interactions. The fact that pH-dependent increases in
foldedness are also associated with the appearance of
plaque competence raises the issue of whether the more
folded state has a higher potential energy than the less
folded state; this could, in turn, give rise to more favorable
energetics for self-association reactions.
If such speculation is verified, then the pKa shifts result-
ing from substitution of Thr for Phe19 create a paradox.
This substitution reduces NOE cross-peaks in the 10–35
fragment [10] and increases amide exchange rates in the
17-mer studied here. A key feature of the conformation of
the CHC within Aβ(10–35)-NH2 is an ‘edge-to-face’
arrangement for Phe20 and Phe19 (respectively), with the
pro-R γ-methyl group of Val18 close to the face of Phe20
([9]; J.P.L., unpublished data). Assuming a similar confor-
mation within the 17-mer, the change in ‘marker’ chemi-
cal shifts suggests that the sidechains at positions 18 and
20 (and to a lesser extent 19) are no longer within the
same proximity. One could guess that the conformational
energy of this less folded state is globally reduced com-
pared with the more folded state where the CHC is promi-
nent. But the pKa of Glu22 increases by 0.4 units (while
the other pKa values also increase), indicating less favor-
able deprotonation reactions for all residues. One possible
explanation is that while the disruption of the CHC may
alter backbone solvent accessibility globally, global con-
formational energy is not simply reduced, rather it is par-
tially redistributed. Hence the observed increases in pKa
values may reflect a redistribution of sidechain–sidechain
interactions, where relief of conformational stress at the
CHC is partially offset by a modest decrease in the solvent
accessibility for the sidechain of Glu22.
Finally, in contrast to classical hydrophobic clusters
involving different secondary structural elements of
soluble globular proteins, the CHC found within Aβ not
only appears to be formed via local interactions, but is also
unlikely to be completely buried deep within the core of a
native structure. Not surprisingly, poor solvation or poor
solubility have remained key elements when considering
possible contributions to the avid self-assembly behavior
of Aβ. Interestingly, evidence for the CHC is not seen
when Aβ and several truncated congeners are dissolved in
mixed organic solvents and/or at low pH values, and under
such conditions self-assembly is generally minimized
[22,25–29]. From the behavior seen within the 17-mers
studied here, and the similar conformational behavior of
Aβ(10–35)-NH2 as well as full-length Aβ in water solution
([8,9]; J.P.L., unpublished data), it seems reasonable that
propagation from the CHC of a non-native hydrophobic
network could be a fundamental thermodynamic tenet
underlying the conformation of Aβ in water solution. It
could be further reasoned that propagation of a hydropho-
bic assembly about the CHC may result in an anomalous
constellation of surface hydrophobic residues which in
turn may have a key role during self-assembly. If this is
true, then perhaps one strategy for competing with the
self-assembly propensity would be to specifically target
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the CHC (or an associated hydrophobic surface) for con-
formational disruption while simultaneously improving
overall solvation energetics and conformational integrity.
Conclusions
The δpKa data for Aβ(12–28) compared with three substi-
tuted congeners do not support the presence of a signifi-
cant salt bridge between His14 and Glu22, and this argues
against intramolecular coulombic interactions as a prereq-
uisite to formation of the CHC within soluble Aβ. In the
absence of hydrogen bonding or coulombic interactions, it
follows that local steric and hydrophobic forces are the
most important contributors to the formation of this domi-
nant structural feature. A potential mechanism for the pH-
dependent conformational change is proposed which is
based upon a solvation imperative for carboxylates flanked
by the CHC and the flanking hydrophobic residues associ-
ated with the CHC nucleus. Furthermore, propagation of
a hydrophobically collapsed coil in solution may result in
formation of a constellation of surface residues on soluble
Aβ which becomes key to amyloidogenic behavior, and
hence the CHC may represent an important target for
potential anti-amyloid drugs.
Materials and methods
Synthetic peptides
Aβ(12–28) (wild type), Aβ(12–28)H13R (rodent), Aβ(12–28)E22Q
(Dutch), and Aβ(12–28)F19T (Figure 1) were purchased or were syn-
thesized by the Merrifield solid-phase methodology [36] on a Milligen
9050 PepSynthesizer, using the 9-fluorenylmethoxycarbonyl (Fmoc)
strategy. After cleavage from the resin, the crude peptides were puri-
fied to homogeneity (>98%) by preparative high performance liquid
chromatography and gave the expected amino acid composition after
acid hydrolysis. Further proof of structure was obtained by fast atom
bombardment mass spectrometry.
NMR sample preparation and pH adjustment for titrations
Dry peptide samples were dissolved to a final concentration of
~ 100 µM in 3 ml 99.9% D2O, containing 0.5 mM trimethylsilyl propi-
onate (TSP) (Cambridge Isotope Laboratory). The pH (direct meter
reading at 25°C) was adjusted with aqueous HCl or NH4OH and the
final volume adjusted to 3.5 ml. Samples were centrifuged and trans-
ferred to 10 mm NMR tubes. Each step in the pH titration was carried
out in parallel for all four samples to minimize error. The total volume of
aqueous ammonia solution added to the 3.5 ml samples during titra-
tions did not exceed ~0.35 ml (increase of less than ~10%).
NMR spectroscopy
1H NMR data were collected on a Varian UNITYplus 500 MHz NMR
machine with the samples maintained at 25°C. A 10 mm 1H pulsed-
field gradient (PFG) probe capable of gradients of >70 gauss/cm was
used for all data collection. Data were collected with spectral widths of
6 kHz in both dimensions using 4096 complex points for F2 and 256
complex points for F1. Chemical shifts were referenced to internal TSP
at 0.00 ppm. All chemical shifts were measured from two-dimensional
(2D) wgsTOCSY spectra [8] acquired in the phase-sensitive mode
using the TPPI-States method [37] and processed using the standard
VNMR 5.3B software release (Varian Associates). Digital filtering of
residual water signal in the time-domain data was used during process-
ing, and additional resolution in the F1 dimension was achieved
through use of linear prediction. Data were processed with zero filling
to a final matrix of 16,384 × 2048 points. Assignments of the peptide
NMR spectra were accomplished using standard analysis methods
relying upon TOCSY and NOESY data acquired as described previ-
ously [8].
Determination of pKa values
Chemical shift changes for H2 of His13 and His14, Hβ1 and Hβ2 of
Asp23 and Hγ1 and Hγ2 of Glu22 were measured from 128 individual
2D TOCSY spectra (32 spectra per peptide). The results were tabu-
lated and the pKa values for each residue within all four peptides were
determined using a three-parameter fitting routine [38] within the Kalei-
dagraph program on a Macintosh computer. Iterative fitting was per-
formed until the correlation coefficient was greater than 0.99.
Amide hydrogen atom relaxation determination
The T1 value of each amide proton from each residue was measured on
a Varian UNITYplus 500 MHz NMR machine, using a progressive satu-
ration recovery sequence with the aid of pulsed-field gradients and
employing WGS water suppression [8]. The average of the two mea-
surements was used to calculate R1 for each residue, R1 = 1/T1.
Amide hydrogen atom exchange rate measurements
Peptides were prepared at 1 mg/ml, pH 7.6 with 20 mM phosphate
buffer, 10% D2O. The NMR spectra were acquired at 20°C, using an
adaptation of the WEX NMR sequence [20,21].
Supplementary material
Assignments for 1H spin systems for Aβ(12–28) and congeners are
published with this paper on the internet.
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Table S1
Resonance assignments for A(12–28)-OH(WT) at 25°C and pH 2.1.
Proton resonance chemical shift (ppm)
Residue NH Hα Hβ Others
Val12 3.78 2.12 0.90, 0.81
His13 9.00 4.72 2.79, 2.77
His14 8.84 4.69 3.20, 3.17
Gln15 8.71 4.32 2.04, 1.97 2.35
Lys16 8.63 4.36 1.91, 1.73 1.43, 1.44
Leu17 8.48 4.34 1.59, 1.53
Val18 8.09 4.03 1.89 0.79, 0.76
Phe19 8.38 4.54 3.10, 3.09 H2,6; 7.22 H3,5; 7.18 H4; 7.16
Phe20 8.26 4.56 2.99, 2.91 H2,6; 7.34 H3,5; 7.31 H4; 7.27
Ala21 8.34 4.21 1.33
Glu22 8.44 4.29 2.09, 1.97 2.47
Asp23 8.51 4.73 2.99, 2.94
Val24 8.24 4.14 2.10 0.91, 0.91
Gly25 8.63 3.98
Ser26 8.26 4.45 3.90
Asn27 8.58 4.68 3.13, 3.08
Lys28 8.01 4.26 1.89, 1.73 1.73, 1.40
Table S2
Resonance assignments for A(12–28)-OH(H13R) at 25°C and pH 2.1.
Proton resonance chemical shift (ppm)
Residue NH Hα Hβ Others
Val12 3.79 2.16 0.94, 0.90
Arg13 4.31 1.76 1.74, 1.58, 3.19
His14 4.72 3.28, 3.19
Gln15 4.34 2.11, 1.96 2.33
Lys16 4.41 1.91, 1.78 1.45, 1.44, 2.98
Leu17 4.34 1.60, 1.56
Val18 4.02 1.91 0.78
Phe19 4.53 3.10, 2.98 H2,6; 7.31 H3,5; 7.19 H4; 7.16
Phe20 4.57 2.93, 2.89 H2,6; 7.35 H3,5; 7.32 H4; 7.27
Ala21 4.20 1.32
Glu22 4.30 2.09, 1.98 2.47
Asp23 4.74 2.97, 2.84
Val24 4.13 2.09 0.96, 0.93
Gly25 3.99
Ser26 4.46 3.88
Asn27 4.71 3.16, 3.13
Lys28 4.33 1.74, 1.73 1.73, 1.40, 3.00
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Table S3
Resonance assignments for A(12–28)-OH(F19T) at 25°C and pH 2.1.
Proton resonance chemical shift (ppm)
Residue NH Hα Hβ Others
Val12 3.80 2.13 0.92, 0.81
His13 8.99 4.72 2.82, 2.77
His14 8.85 4.71 3.24, 3.18
Gln15 8.68 4.32 2.11, 2.02 2.35
Lys16 8.59 4.37 1.89, 1.74 1.42, 1.41, 2.99
Leu17 8.44 4.37 1.64, 1.56 0.84
Val18 8.27 4.12 1.95 0.85, 0.83
Thr19 8.16 4.30 4.12 1.12
Phe20 8.32 4.61 3.14, 3.02 H2,6; 7.34 H3,5; 7.30 H4; 7.25
Ala21 8.34 4.29 1.32
Glu22 8.30 4.32 2.10, 2.00 2.46
Asp23 8.56 4.77 2.88, 2.87
Val24 8.33 4.14 2.13 1.09, 0.99
Gly25 8.56 3.98
Ser26 8.27 4.49 3.86
Asn27 8.56 4.70 3.12, 3.08
Lys28 8.16 4.27 1.75, 1.73 1.40, 1.40, 3.00
Table S4
Resonance assignments for A(12–28)-OH(E22Q) at 25°C and pH 2.1.
Proton resonance chemical shift (ppm)
Residue NH Hα Hβ Others
Val12 3.78 2.12 0.91, 0.85
His13 4.72 2.80, 2.76
His14 4.69 3.23, 3.18
Gln15 4.29 2.05, 1.98 2.35
Lys16 4.36 1.93, 1.75 1.42, 1.41, 3.00
Leu17 4.33 1.61, 1.57 0.87
Val18 4.03 1.90 0.78, 0.76
Phe19 4.54 3.10, 3.01 H2,6; 7.23 H3,5; 7.21 H4; 7.17
Phe20 4.55 2.90, 2.88 H2,6; 7.343 H3,5; 7.31 H4; 7.28
Ala21 4.20 1.34
Gln22 4.30 2.01, 2.00 2.34
Asp23 4.73 2.96, 2.86
Val24 4.14 2.11 0.95, 0.94
Gly25 3.99
Ser26 4.45 3.88
Asn27 4.68 3.13, 3.08
Lys28 4.27 1.81, 1.73 1.43, 1.40, 2.98
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Table S5
Resonance assignments for A(12–28)-OH(WT) at 25°C and pH 7.36.
Proton resonance chemical shift (ppm)
Residue NH Hα Hβ Others
Val12 3.62 2.05 0.90, 0.81
His13 4.72 2.75
His14 4.72 2.88
Gln15 4.22 2.04, 1.97 2.24
Lys16 8.50 4.25 1.91, 1.73 1.43, 1.44
Leu17 8.32 4.35 1.61, 1.52
Val18 8.00 4.03 1.91 0.78, 0.75
Phe19 8.26 4.57 3.14, 3.09 H2,6; 7.25 H3,5; 7.19 H4; 7.17
Phe20 8.23 4.56 2.99, 2.93 H2,6; 7.35 H3,5; 7.33 H4; 7.29
Ala21 8.26 4.12 1.32
Glu22 8.39 4.29 2.02, 1.78 2.27
Asp23 8.44 4.64 2.75, 2.64
Val24 8.15 4.16 2.18 0.94, 0.94
Gly25 8.55 3.99
Ser26 8.20 4.44 3.88
Asn27 8.44 4.69 2.84, 2.78
Lys28 7.93 4.17 1.84, 1.66 1.65, 1.35
Table S6
Resonance assignments for A(12–28)-OH(H13R) at 25oC and pH 7.68.
Proton resonance chemical shift (ppm)
Residue NH Hα Hβ Others
Val12 3.53 1.96 0.94, 0.90
Arg13 7.92 4.29 1.73 1.76, 1.58, 3.17
His14 4.62 3.08, 3.06
Gln15 8.44 4.31 2.11, 1.96 2.26
Lys16 8.44 4.24 1.91, 1.78 1.45, 1.44, 2.97
Leu17 8.32 4.36 1.60, 1.55
Val18 7.98 4.04 1.91 0.77
Phe19 8.26 4.56 3.08, 3.03 H2,6; 7.31 H3,5; 7.19 H4; 7.16
Phe20 8.22 4.57 2.93, 2.89 H2,6; 7.35 H3,5; 7.32 H4; 7.27
Ala21 8.26 4.11 1.31
Glu22 8.38 4.24 2.09, 1.98 2.23
Asp23 8.44 4.62 2.62, 2.73
Val24 8.14 4.16 2.16 0.96, 0.93
Gly25 8.52 3.99
Ser26 8.18 4.48 3.85
Asn27 8.44 4.65 2.78, 2.72
Lys28 8.02 4.22 1.74, 1.73 1.73, 1.40, 2.96
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Table S7
Resonance assignments for A(12–28)-OH(F19T) at 25oC and pH 7.2.
Proton resonance chemical shift (ppm)
Residue NH Hα Hβ Others
Val12 3.67 2.07 0.92, 0.83
His13 4.73 2.82, 2.76
His14 4.65 3.06, 3.02
Gln15 8.42 4.23 2.08, 2.01 2.22
Lys16 8.46 4.36 1.89, 1.74 1.42, 1.41, 3.00
Leu17 8.35 4.39 1.64, 1.56 0.85
Val18 8.23 4.14 1.98 0.89, 0.85
Thr19 8.16 4.32 4.13 1.10
Phe20 8.33 4.57 3.09, 3.02 H2,6; 7.36 H3,5; 7.31 H4; 7.27
Ala21 8.32 4.29 1.34
Glu22 8.38 4.29 2.10, 2.00 2.32
Asp23 8.44 4.64 2.75, 2.63
Val24 8.16 4.13 2.13 1.10, 0.99
Gly25 8.56 3.99
Ser26 8.20 4.46 3.89
Asn27 8.44 4.73 2.89, 2.85
Lys28 7.93 4.28 1.75, 1.73 1.40, 1.40, 3.00
Table S8
Resonance assignments for A(12–28)-OH(E22Q) at 25°C and pH 7.23.
Proton resonance chemical shift (ppm)
Residue NH Hα Hβ Others
Val12 3.56 1.99 0.87, 0.76
His13 4.73 2.80, 2.76
His14 4.59 3.04, 3.00
Gln15 8.34 4.27 2.01, 1.94 2.29
Lys16 8.48 4.31 1.95, 1.72 1.36, 1.36, 2.99
Leu17 8.31 4.34 1.61, 1.58 0.85
Val18 8.02 4.05 1.89 0.76, 0.75
Phe19 8.26 4.57 3.13, 3.05 H2,6; 7.25 H3,5; 7.20 H4; 7.18
Phe20 8.21 4.57 2.96, 2.91 H2,6; 7.35 H3,5; 7.32 H4; 7.29
Ala21 8.28 4.23 1.34
Gln22 8.33 4.28 2.02, 2.02 2.34
Asp23 8.46 4.64 2.76, 2.65
Val24 8.19 4.16 2.15 0.92, 0.91
Gly25 8.56 3.99
Ser26 8.21 4.45 3.88
Asn27 8.46 4.74 2.89, 2.85
Lys28 7.94 4.18 1.81, 1.66 1.40, 1.44, 2.98
Supplementary material S5
Table S9
Exchange lifetimes (in seconds) for amide hydrogen atoms
(with water solvent) at 20°C.
Residue WT E22Q H13R F19T
12
13
14
15 0.067 0.075 0.062
16 0.045 0.039 0.075 0.058
17 0.101 0.075 0.061 0.057
18 0.481 0.337 0.247 0.102
19 0.107 0.081 0.064 0.106
20 0.098 0.090 0.062 0.056
21 0.107 0.075 0.068 0.057
22 0.164 0.067 0.097 0.079
23 0.113 0.075 0.076 0.069
24 0.331 0.120 0.193 0.106
25 0.062 0.045 0.049 0.044
26 0.066 0.075 0.062 0.057
27 0.113 0.075 0.075 0.069
28 4.190 3.776 0.564 1.297
